More than 50 latent TB cases and three active infections prompt Riordan High School to halt in‑person classes and expand ...

India's pharma sector is moving towards high-value products like complex generics and biosimilars. The medical devices ...

India’s pharmaceutical industry is shifting from a volume-driven to a value-driven approach, with greater emphasis on complex ...

With 2026 set to be a banner year for M&A as buyers facing patent cliffs compete for a limited pool of late-stage assets [3], ...

The poster presentation will include updated safety and efficacy data from approximately 25 six-month evaluable BCG-Unresponsive NMIBC patients in the ongoing Phase 2 ADVANCED-2 trial. ADVANCED-2 ...

Detailed price information for Engene Holdings Inc (ENGN-Q) from The Globe and Mail including charting and trades.

IBRX stock jumps 17% after FDA talks outline the path to resubmit Anktiva sBLA for papillary NMIBC, with additional analyses done and filing planned soon.

We recently published 10 Stocks Breaking Records While Wall Street Bleeds. ImmunityBio Inc. (NASDAQ:IBRX) was one of the top ...

BOSTON & MONTREAL, January 20, 2026--enGene Holdings Inc. (Nasdaq: ENGN, "enGene" or the "Company"), a clinical-stage, ...

European shares were lower today. The eurozone's STOXX 600 fell 0.92%, while Spain's IBEX 35 Index fell 1.35%. London's FTSE 100 dipped 0.97%, Germany's DAX fell 1.14% and France's CAC 40 slipped 0.86 ...

ImmunityBio shares were 36% higher, at $7.52, after the company said it recently held a Type B End-of-Phase meeting with the Food and Drug Administration regarding its supplemental Biologics License ...

The 'Victorian disease' refers to tuberculosis (TB), which affects the lungs and spreads through droplets in the air when a ...